Rare blood clots from AstraZeneca vaccine mostly affect younger people
By Clive Cookson & Anna Gross
AstraZeneca's vaccine has brought in $275 million in sales so far this year. (Published 2021)
By Rebecca Robbins
British regulator cites 41 more blood clot reports following AstraZeneca shots
By Bernadette Baum & Alistair Smout